Compare IPSC & SES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IPSC | SES |
|---|---|---|
| Founded | 2019 | 2012 |
| Country | United States | United States |
| Employees | N/A | 215 |
| Industry | Medicinal Chemicals and Botanical Products | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 441.9M | 384.1M |
| IPO Year | 2021 | N/A |
| Metric | IPSC | SES |
|---|---|---|
| Price | $2.20 | $0.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $4.25 | $4.00 |
| AVG Volume (30 Days) | 2.1M | ★ 10.9M |
| Earning Date | 05-11-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.30 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $109,164,000.00 | N/A |
| Revenue This Year | N/A | $53.90 |
| Revenue Next Year | N/A | $111.26 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1556.76 | N/A |
| 52 Week Low | $0.44 | $0.70 |
| 52 Week High | $2.97 | $3.73 |
| Indicator | IPSC | SES |
|---|---|---|
| Relative Strength Index (RSI) | 44.35 | 28.12 |
| Support Level | $2.14 | N/A |
| Resistance Level | $2.56 | $1.01 |
| Average True Range (ATR) | 0.19 | 0.07 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 25.53 | 0.77 |
Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.
SES AI Corp is a developer and manufacturer of rechargeable battery technologies and battery materials for Energy Storage Systems (ESS), Urban Air Mobility (UAM), drones, robotics, electric vehicles (EVs), and other applications. For Enery Storage Systems, the company supplies hardware and software solutions with battery health and safety management software powered by its AI-based platform, Molecular Universe. Additionally, it offers battery materials and high-energy and power-density Li-Metal and Li-ion cells, which can be used for drones, UAM, robotics, and EV applications. The company also offers access to Molecular Universe as a software product. Currently, it generates maximum revenue from the development of Li-ion and Li-Metal battery materials as per the client's specifications.